Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Pfizer prepares new beta3-adrenoceptor agonists

May 13, 1998

Novartis begins phase III trial with Aredia in prostate cancer patients

May 12, 1998

Cysteine protease inhibitors synthesized at SKB claimed for osteoporosis, arthritis, periodontitis

May 11, 1998

Initial results in the development of gene therapy for OI reported by NIH

May 11, 1998

Serono introduces Geref for treatment/diagnosis of GHD

May 8, 1998

CP-336156: nonsteroidal estrogen agonist/antagonist with a better profile than estrogen

May 8, 1998

Osiris awarded patent for the use of MSCs in bone marrow regeneration

May 8, 1998

FDA approves improved oral contraceptive agent

May 7, 1998

ArQule and Beth Israel enter collaboration for osteopenic disease drug discovery

May 7, 1998

OCT: suppression of PTH secretion in mouse model of severe parathyroid hyperplasia

May 7, 1998

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...